Cargando…
Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach
Global prophylactic vaccination programmes have helped to curb new hepatitis B virus (HBV) infections. However, it is estimated that nearly 300 million people are chronically infected and have a high risk of developing hepatocellular carcinoma. As such, HBV remains a serious health priority and the...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218364/ https://www.ncbi.nlm.nih.gov/pubmed/34163105 http://dx.doi.org/10.3748/wjg.v27.i23.3182 |